Please assess the completion status of the following clinical trial:

Trial Title: Multidrug Blister Pack Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age over 18 years~* Prescription of 4 or more different oral solid drugs~* Capable to understand german (verbally and written)~* Capable to give informed consent~* Insured by a Swiss health insurance~* Manages his/her pharmacotherapy without external support~* Obtains his/her medication from a community pharmacy~* Accepts to use an electronic multidrug blister pack~* Place of domicile in Basel-Stadt or Basel-Land~Exclusion Criteria:~* Pregnancy~* \> 2 drugs that cannot be packed into a multidrug blister pack (e.g. fluids)~* Dementia, or evaluated as cognitively impaired by the responsible nurse~* Transplanted patient~* Anticoagulation with oral vitamin K antagonists~* Has already used a multidrug blister pack of Pharmis or a Medifilm® single dose system~* is visually impaired (blind)~* cannot push drugs through a blister~* refuses to allow contact to his/her regular pharmacy and GP~* is referred to a nursing home or to rehabilitation or another hospital at discharge~* is included in other clinical trial

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Control (Type: NO_INTERVENTION): At hospital discharge, patients of the control group will receive usual care at their community pharmacy.
- Electronic Multidrug Blister Pack (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).